More immunotherapy for multiple sclerosis

被引:19
作者
Hughes, RAC
Sharrack, B
机构
关键词
D O I
10.1136/jnnp.61.3.239
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:239 / 241
页数:3
相关论文
共 44 条
[1]  
[Anonymous], NEUROLOGY
[2]   A CONTROLLED TRIAL OF MITOXANTRONE IN MULTIPLE-SCLEROSIS - SERIAL MRI EVALUATION AT ONE-YEAR [J].
BASTIANELLO, S ;
POZZILLI, C ;
DANDREA, F ;
MILLEFIORINI, E ;
TROJANO, M ;
MORINO, S ;
GASPERINI, C ;
BOZZAO, A ;
GALLUCCI, M ;
ANDREULA, C ;
BOZZAO, L ;
GAMBI, D ;
PRENCIPE, M .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (03) :266-270
[3]   The treatment of chronic progressive multiple sclerosis with cladribine [J].
Beutler, E ;
Sipe, JC ;
Romine, JS ;
Koziol, JA ;
McMillan, R ;
Zyroff, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1716-1720
[4]   A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, 2-CENTER, PILOT TRIAL OF COP 1 IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
BORNSTEIN, MB ;
MILLER, A ;
SLAGLE, S ;
WEITZMAN, M ;
DREXLER, E ;
KEILSON, M ;
SPADA, V ;
WEISS, W ;
APPEL, S ;
ROLAK, L ;
HARATI, Y ;
BROWN, S ;
ARNON, R ;
JACOBSOHN, I ;
TEITELBAUM, D ;
SELA, M .
NEUROLOGY, 1991, 41 (04) :533-539
[5]   A PILOT TRIAL OF COP-1 IN EXACERBATING REMITTING MULTIPLE-SCLEROSIS [J].
BORNSTEIN, MB ;
MILLER, A ;
SLAGLE, S ;
WEITZMAN, M ;
CRYSTAL, H ;
DREXLER, E ;
KEILSON, M ;
MERRIAM, A ;
WASSERTHEILSMOLLER, S ;
SPADA, V ;
WEISS, W ;
ARNON, R ;
JACOBSOHN, I ;
TEITELBAUM, D ;
SELA, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) :408-414
[6]   LOW-DOSE ORAL METHOTREXATE TREATMENT OF MULTIPLE-SCLEROSIS - A PILOT-STUDY [J].
CURRIER, RD ;
HAERER, AF ;
MEYDRECH, EF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11) :1217-1218
[7]   CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRI ACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY [J].
FILIPPI, M ;
PATY, DW ;
KAPPOS, L ;
BARKHOF, F ;
COMPSTON, DAS ;
THOMPSON, AJ ;
ZHAO, GJ ;
WILES, CM ;
MCDONALD, WI ;
MILLER, DH .
NEUROLOGY, 1995, 45 (02) :255-260
[8]  
FILIPPI M, 1994, NEUROLOGY, V44, P638
[9]   AN ASSESSMENT OF DISABILITY RATING-SCALES USED IN MULTIPLE-SCLEROSIS [J].
FRANCIS, DA ;
BAIN, P ;
SWAN, AV ;
HUGHES, RAC .
ARCHIVES OF NEUROLOGY, 1991, 48 (03) :299-301
[10]   LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
GOODKIN, DE ;
RUDICK, RA ;
MEDENDORP, SV ;
DAUGHTRY, MM ;
SCHWETZ, KM ;
FISCHER, J ;
VANDYKE, C .
ANNALS OF NEUROLOGY, 1995, 37 (01) :30-40